Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-18

Clinical Trial Update: Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia [Phase 3]

View source ↗

Summary

Phase 3 trial update for a fixed-dose combination of atorvastatin and perindopril in adults with arterial hypertension and dyslipidemia; study status is termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • atorvastatin + perindopril fixed-dose combination S05167

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Dyslipidemias, Hypertension | Phase 3 | Status: TERMINATED